Single-cell sequencing: New insights for intervertebral disc degeneration

Biomed Pharmacother. 2023 Sep:165:115224. doi: 10.1016/j.biopha.2023.115224. Epub 2023 Jul 27.

Abstract

Over the past decade, single-cell RNA sequencing (scRNA-seq) has revolutionized research on biological mechanisms of diseases. Moreover, this technique has been utilized to identify and characterize unique cell types and subpopulations, thereby illuminating cellular heterogeneity. The true value of scRNA-seq lies in its ability to detect transcriptional alterations or perturbed pathways within specific cell types under pathological conditions. In the context of intervertebral disc degeneration (IVDD), the pathophysiological foundation is largely rooted in inflammation. The primary target cells of IVDD are nucleus pulposus cells, annulus fibrosus cells, cartilage endplate cells, and macrophages. The advancements in scRNA-seq technology have triggered remarkable progress in IVDD treatment, leading to breakthroughs in the identification of cell subsets, functional analysis, novel therapeutic targets, and the differentiation and development of various cell types. This review is the first of its kind to introduce the application of scRNA-seq techniques in IVDD, with a focus on the most recent scRNA-seq studies that have defined the populations of various cell types and specific cell-cell interactions in IVDD. Furthermore, we highlight several promising future research directions for scRNA-seq in IVDD.

Keywords: Annulus fibrosus; Intervertebral disc degeneration; Macrophages; Nucleus pulposus; Single-cell sequencing.

Publication types

  • Review

MeSH terms

  • Annulus Fibrosus* / metabolism
  • Annulus Fibrosus* / pathology
  • Humans
  • Inflammation / metabolism
  • Intervertebral Disc Degeneration* / pathology
  • Intervertebral Disc* / metabolism
  • Nucleus Pulposus* / metabolism